Formulation, characterization,and stability of protein drugs:case histories edited by Rodney Pearlman and Y.John Wang
Material type:![Text](/opac-tmpl/lib/famfamfam/BK.png)
Item type | Current library | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
![]() |
NISER LIBRARY | 615.32 PEA-F (Browse shelf(Opens below)) | R (REFERENCE) | 8177 |
Browsing NISER LIBRARY shelves Close shelf browser (Hides shelf browser)
615.32 LU-E Enzyme inhibition in drug discovery and development: the good and the bad | 615.32 MER-D Drug design:structure and ligand based approaches | 615.32 MER-D Drug design: structure and ligand based approaches | 615.32 PEA-F Formulation, characterization,and stability of protein drugs:case histories | 615.32 ZHO-M Multi-drug resistance in cancer | 615.32 ZHO-M Multi-drug resistance in cancer | 615.36 KLE-P Protein kinases as drug targets |
There are no comments on this title.